AGC Biologics Email Format
Pharmaceutical ManufacturingWashington, United States1001-5000 Employees
AGC Biologics is a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) in the pharmaceutical manufacturing industry, based in Bothell, Washington, with a workforce of about 1,000 to 5,000 employees. The company provides development and manufacturing services for mammalian and microbial-based therapeutic proteins, as well as plasmid DNA, mRNA, viral vectors, and genetically engineered cell therapies. Its global network includes cGMP-compliant facilities in Seattle, Washington; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and in Chiba and Yokohama, Japan. In 2026, AGC Biologics expanded its presence in Japan with a new Yokohama facility and an expansion in Chiba to support process development and GMP manufacturing for clinical trials, and it signed a microbial CDMO contract with Teikoku Seiyaku Co., Ltd. The company has received industry recognition for regulatory and quality leadership, client service, and manufacturing performance.